innovation pathway -...

19
Innovation Pathway Russ Watkins Assistant Director Business Innovation & Improvement

Upload: buithien

Post on 24-Aug-2019

213 views

Category:

Documents


0 download

TRANSCRIPT

Innovation Pathway

Russ Watkins

Assistant Director – Business Innovation & Improvement

Why is Newcastle Hospitals a

partner in the innovation pathway?• One of the top teaching hospital in the

country

• Only tertiary centre to receive ‘outstanding’

from the CQC

• Has the largest number of specialist

services in the country

• Has the highest number of patients

entered in commercial trials

Specialist expertise• Clinical expertise to call upon

• Specialist and innovative services

– Newcastle Specials

– Great North Children’s Hospital

– Da vinci robot service and training

– Newcastle Surgical Training Centre

• Joint Research infrastructure with

Newcastle University

The Basic Foundation

Culture and Ideas

Pause

If only we had!

Why do we do it this way? If we can just find a way of doing

Why is there not a bit of kit that does this? What we really need is?

Surely there is a better way

I’ve had an idea where do I go / What

do I do with it!

Business & Development Managers

Innovation Scouts - Front line staff trained in IP

Core understanding of the culture of innovation in the Trust

Peer support for generating ideas and seeking out problems

Policy

Finance

PBR

CQUIN

5 Year

Forward

view

DH DirectivesNICE

Service

Specifications

Patient

New

Technology

New DrugsImproving Pathways

Patient

Feedback

TrialsResearch

Commercial

EXTERNAL FUNDING

AHSN LEP

Charites Shine

RIF Grant

Application HENE

Venture Capital

AWARDS / REWARDS

HSJ Award

Bright Ideas

NUTH Celebrations

PROCESSES

Innovation @ NUTH

Face to face Meetings

Relevant Information

Data Set/Research/Audit

WHO

Business &

Development

Finance

JRE

Service

Improvement

Transformation

RMPD

IT

Education &

Training

Patient Services

DMs & CDs

COMMITTEES

Executive Team

Trust Board

Clinical Governance

Joint Business

Executive

Joint Research

Executive

Ethics Committee

Investment

Committee

Trust Education

Group

Business Planning

Transformation/CIP

OTHER

CONSIDERATIO

NS

Integration

Partnerships

Strategic Alliances

Choice & Competition

Procurement

Better care Fund

EDUCATION &

TRAINING

Simulation Centre

Surgical Centre

University

Courses

In -house Training

Commercial Units

RESEARCH &

DEVELOPMENT

JRO/NUTH University

Research Strategy

Newcastle Led

Patient Recruitment

Trials - commercial

- non-

commercial

SERVICE

IMPROVEMENT

Soft IP

Transformation

Training & Support

Methodologies

Patient Pathways

COMMERCIAL

Licenses

Spin-out

Commercial

Framework

DEC/EAC

RMPD Developments

AHSN/NHSA

University

Industry Liaison

E-HEALTH

Telehealth

Telecommunications

APPS

IT Platform

Software

Development

EPR

BUSINESS &

DEVELOPMENT

Commissioning Link

Directorate Links

Contracting

Federation Liaison

Local Authority Links

PATIENT

SERVICES

Nursing

Developments

AHP Developments

Outpatients

PPI

INFRASTRUCTURE

Estates

Pharmacy Radiology

Laboratory Medicine

Commissionin

g intentions

IM&T

Marketing & Publicity

Innovation

HR

What areas are the ideas submitted falling into?

Device 34

Software 10

Service Improvement 20

Education & Training 6

e-health 14

Fund raising 1

e-learning 1

Research 3

Other 2

App 2

HR 2

Grand Total 95

Commercial 47

service improvement 8

Patient Services 4

Education & Training 7

IT 17

Transformation 3

Catering 1

Research 3

Business & Development 1

Estates 2

HR 2

Grand Total 95

Natural Cohesion

Newcastle Academic Health

Partners

Research & Innovation

Newcastle

Translation

al Research

Facilities

(NCRF)(Operations

Group)

Cellular

Therapies(Anne

Dickinson)

Biobank(Andy Hall)

The Research Infrastructure Review

One-Stop-Shop Model

Scientifi

c

Facilitie

s(Deb

Henderson)

Centre for

In Vivo

Imaging

(Andy

Blamire)

PET (R

Maxwell)

MR (R

Taylor)PET/MR

(new)

Pre-clinicalPET

(CAV

)

MR

(CB

C

CTU(Elaine

McColl)

Enterprise(Martin Cox)

JRO

(Amanda Tortice)

Researcher

Local Clinical

Research Networks (LCRN)

BRC/BRU

Delivery Teams

Academic Health

Sciences Network (AHSN)

Academic Clinical

Directorate (ACD)

Key:

Phase 1

Phase 2

Phase 3

Institutes

Central

CRF(Mark Walker)

CTSN (David Burn)

Dental(Phillip

Preshaw)

CARU (David Burn)

SBRU (Ruth

Plummer)

Paediatric(Josef

Vormoor)

Cyclotron

(J Vormoor)

Diagnostics:Pathology Node

Diagnostic Evidence

Co-Operative (DEC)

IVI

S

Regional Design

Service (RDS)

Newcastle

Translation

al Research

Facilities

(NCRF)(Operations

Group)

Cellular

Therapies(Anne

Dickinson)

Biobank(Andy Hall)

The Research Infrastructure Review

One-Stop-Shop Model

Scientifi

c

Facilitie

s(Deb

Henderson)

Centre for

In Vivo

Imaging

(Andy

Blamire)

PET (R

Maxwell)

MR (R

Taylor)PET/MR

(new)

Pre-clinicalPET

(CAV

)

MR

(CB

C

CTU(Elaine

McColl)

Enterprise(Martin Cox)

JRO

(Amanda Tortice)

Research

er

Local Clinical

Research Networks (LCRN)

BRC/BRU

Delivery Teams

Academic Health

Sciences Network (AHSN)

Academic Clinical

Directorate (ACD)

Key:

Phase 1

Phase 2

Phase 3

Institutes

Central

CRF(Mark Walker)

CTSN (David Burn)

Dental(Phillip

Preshaw)

CARU (David Burn)

SBRU (Ruth

Plummer)

Paediatric(Josef

Vormoor)

Cyclotron

(J Vormoor)

Diagnostics:Pathology Node

Diagnostic Evidence

Co-Operative (DEC)

IVI

S

Regional Design

Service (RDS)

Newcastle Research & Innovation Hub

Wider areas of development

Further developed the Relationship with the AHSN through:

•Supporting the development of the programme of innovation in the Trust

•Supporting the ability to have Business Development Managers in the Trust

•Supporting the on the ground development of understanding of Intellectual

Property and supporting peer support for ideas through the Innovation Scout

Programme

•Supporting being part of the Innovation Pathway

Work with Newcastle University:

•Research and Innovation Hub Industry focussed joint awards of contracts for

Diagnostic Evidence Co-operative and Pathology Node

The Killer Question of Adoption

• Evidence and Clinical Validity

• Who is the buyer / Commissioner?

• Where in the clinical pathway is the benefit?

• What is it going to save – and who benefits from

that? - NHS has perverse incentives

• NHS is bankrupt

Brokering

Industry with clinician = Co-development

We both need each other

• Clinical Innovation requires support of industry to

commercialise ideas

• Industry require clinical input to develop the product

• Key is to get the right combination

• AHSN – Research & Innovation Hub

= Better Patient Care

Thank You

[email protected]